[Development and validation of a tool for the systematic identification of social vulnerabilities in cancer patients: the DEFCO tool].

Journal: Bulletin du cancer
PMID:

Abstract

INTRODUCTION: Literature suggests that patients from deprived backgrounds are less likely to adhere to their treatments, continue to expose themselves to risk factors and, as a result, have poorer health outcomes. It is therefore crucial to identify these vulnerable populations early on, in order to provide them with tailored and reinforced care. The primary aim of this research is to construct and validate a systematic screening tool for identifying patients at highest risk of social vulnerability due to deprivation, through the use of psychometric techniques. This tool is intended to be easily used by healthcare professionals, to provide tailored and targeted care throughout the patient's journey.

Authors

  • Amandine Baudot
    CIC 1408 - Inserm, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France; Institut Presage, Université Jean Monnet, Saint-Étienne, France. Electronic address: Amandine.baudot@chu-st-etienne.fr.
  • Vanessa Dutertre
    Institut de cancérologie et d'hématologie universitaire de Saint-Étienne, Saint-Étienne, France.
  • Mathieu Oriol
    Centre technique d'appui et de formation des centres d'examens de santé (CETAF), Saint-Étienne, France.
  • Véronique Regnier-Denois
    Institut Presage, Université Jean Monnet, Saint-Étienne, France.
  • Marie-Agnès Bourg
    Centre Jean Perrin, Clermont-Ferrand, France.
  • Dominique Feld
    Institut de cancérologie et d'hématologie universitaire de Saint-Étienne, Saint-Étienne, France.
  • Linjie Chen
    Maiplex System, La Pacaudière, France.
  • Fabien Tinquaut
    Service de santé publique et d'information médicale, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France.
  • Franck Chauvin
    CIC 1408 - Inserm, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France; Institut Presage, Université Jean Monnet, Saint-Étienne, France.
  • Aurélie Bourmaud
    Unité de recherche clinique, Hôpital Universitaire Robert Debré AP-HP, CIC-1426, Paris, France; Inserm 1137 IAME, Paris, France.